{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:02:59Z","timestamp":1785456179031,"version":"3.56.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.esmoop.2023.101598","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T12:30:56Z","timestamp":1689597056000},"page":"101598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["An Italian multicenter retrospective real-life analysis of patients with brain metastases from renal cell carcinoma: the BMRCC study"],"prefix":"10.1016","volume":"8","author":[{"given":"V.","family":"Intern\u00f2","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Massari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Rud\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.A.","family":"Maiorano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Caffo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Procopio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bracarda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Atzori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Passarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bersanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Stellato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Fornarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Galli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Zanardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Incorvaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Facchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.R.","family":"Giron Berrios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Ricotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Santoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Funaioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Trerotoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Porta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.esmoop.2023.101598_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2017.06.060","article-title":"Metastatic renal cell carcinoma: patterns and predictors of metastases\u2014a contemporary population-based series","volume":"35","author":"Chandrasekar","year":"2017","journal-title":"Urol Oncol"},{"key":"10.1016\/j.esmoop.2023.101598_bib2","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/neuonc\/nox077","article-title":"Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study","volume":"19","author":"Cagney","year":"2017","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.esmoop.2023.101598_bib3","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.euf.2017.12.007","article-title":"The development of brain metastases in patients with renal cell carcinoma: epidemiologic trends, survival, and clinical risk factors using a population-based cohort","volume":"5","author":"Sun","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.esmoop.2023.101598_bib4","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.clgc.2018.11.007","article-title":"Improved survival outcomes for kidney cancer patients with brain metastases","volume":"17","author":"Bowman","year":"2019","journal-title":"Clin Genitourin Cancer"},{"issue":"1","key":"10.1016\/j.esmoop.2023.101598_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-97365-6","article-title":"The prognosis and clinico-pathological features of different distant metastases patterns in renal cell carcinoma: an analysis based on the SEER database","volume":"11","author":"Wei","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.esmoop.2023.101598_bib6","first-page":"54","article-title":"Delayed brain metastasis from renal cell carcinoma","volume":"22","author":"Kolsi","year":"2018","journal-title":"Urol Case Rep"},{"key":"10.1016\/j.esmoop.2023.101598_bib7","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s10585-015-9748-8","article-title":"Early identification of asymptomatic brain metastases from renal cell carcinoma","volume":"32","author":"Hanzly","year":"2015","journal-title":"Clin Exp Metastasis"},{"issue":"6","key":"10.1016\/j.esmoop.2023.101598_bib8","doi-asserted-by":"crossref","first-page":"e1163","DOI":"10.1016\/j.clgc.2019.08.006","article-title":"Brain metastasis from renal-cell carcinoma: an institutional study","volume":"17","author":"Suarez-Sarmiento","year":"2019","journal-title":"Clin Genitourin Cancer"},{"issue":"5","key":"10.1016\/j.esmoop.2023.101598_bib9","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/neuros\/nyy436","article-title":"Hemorrhagic and cystic brain metastases are associated with an increased risk of leptomeningeal dissemination after surgical resection and adjuvant stereotactic radiosurgery","volume":"85","author":"Press","year":"2019","journal-title":"Neurosurgery"},{"issue":"32","key":"10.1016\/j.esmoop.2023.101598_bib10","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1200\/JCO.20.01255","article-title":"Survival in patients with brain metastases: summary report on the updated diagnosis-specific graded prognostic assessment and definition of the eligibility quotient","volume":"38","author":"Sperduto","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.esmoop.2023.101598_bib11","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.21873\/anticanres.13431","article-title":"Brain metastasis and renal cell carcinoma: prognostic scores assessment in the era of targeted therapies","volume":"39","author":"El Ali","year":"2019","journal-title":"Anticancer Res"},{"issue":"9","key":"10.1016\/j.esmoop.2023.101598_bib12","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.3390\/cancers13092114","article-title":"Prognostic factors and current treatment strategies for renal cell carcinoma metastatic to the brain: an overview","volume":"13","author":"Intern\u00f2","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.esmoop.2023.101598_bib13","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/cncr.23769","article-title":"Brain metastasis from renal cell carcinoma: presentation, recurrence, and survival","volume":"113","author":"Shuch","year":"2008","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.esmoop.2023.101598_bib14","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.clgc.2013.04.012","article-title":"Prognostic factors of survival for patients with metastatic renal cell carcinoma with brain metastases treated with targeted therapy: results from the international metastatic renal cell carcinoma database consortium","volume":"11","author":"Vickers","year":"2013","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.esmoop.2023.101598_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2022.102377","article-title":"New first-line immunotherapy-based combinations for metastatic renal cell carcinoma: a systematic review and network meta-analysis","volume":"106","author":"Lombardi","year":"2022","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"10.1016\/j.esmoop.2023.101598_bib16","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/MOU.0000000000000870","article-title":"Individualizing renal cell carcinoma treatment through biomarkers discovery in the era of immune checkpoint inhibitors: where do we stand?","volume":"31","author":"Porta","year":"2021","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.esmoop.2023.101598_bib17","doi-asserted-by":"crossref","DOI":"10.1177\/17562872211022870","article-title":"Second-line treatment in renal cell carcinoma: clinical experience and decision making","volume":"13","author":"Guadalupi","year":"2021","journal-title":"Ther Adv Urol"},{"issue":"3","key":"10.1016\/j.esmoop.2023.101598_bib18","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/14737140.2019.1574574","article-title":"Targeting angiogenesis in metastatic renal cell carcinoma","volume":"19","author":"Canino","year":"2019","journal-title":"Expert Rev Anticancer Ther"},{"issue":"12","key":"10.1016\/j.esmoop.2023.101598_bib19","doi-asserted-by":"crossref","first-page":"6290","DOI":"10.3390\/ijms22126290","article-title":"Multidiscipline immunotherapy-based rational combinations for robust and durable efficacy in brain metastases from renal cell carcinoma","volume":"22","author":"Lee","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.esmoop.2023.101598_bib20","doi-asserted-by":"crossref","first-page":"CNS28","DOI":"10.2217\/cns-2018-0007","article-title":"Use of the Response Assessment in Neuro-Oncology (RANO) criteria in clinical trials and clinical practice","volume":"8","author":"Chukwueke","year":"2019","journal-title":"CNS Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2023.101598_bib22","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1016\/S1470-2045(17)30693-9","article-title":"Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group","volume":"19","author":"Camidge","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.esmoop.2023.101598_bib23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0210-4806(07)73628-8","article-title":"Molecular biology of the clear cell renal cell carcinoma: principles for a selective treatment","volume":"31","author":"Pulido","year":"2007","journal-title":"Actas Urol Esp"},{"issue":"5","key":"10.1016\/j.esmoop.2023.101598_bib24","first-page":"454","article-title":"An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma","volume":"72","author":"Hasanov","year":"2022","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.esmoop.2023.101598_bib25","doi-asserted-by":"crossref","first-page":"e273","DOI":"10.1016\/j.clgc.2018.11.006","article-title":"Stereotactic radiosurgery for multiple brain metastases from renal-cell carcinoma","volume":"17","author":"Wardak","year":"2019","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.esmoop.2023.101598_bib26","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.3389\/fonc.2020.01246","article-title":"Impact of tyrosine kinase inhibitors (TKIs) combined with radiation therapy for the management of brain metastases from renal cell carcinoma","volume":"10","author":"Khan","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.esmoop.2023.101598_bib27","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1200\/JCO.18.02218","article-title":"Safety and efficacy of nivolumab in brain metastases from renal cell carcinoma: results of the GETUG-AFU 26-NIVOREN multicenter phase II study","volume":"37","author":"Flippot","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"suppl 6","key":"10.1016\/j.esmoop.2023.101598_bib28","article-title":"Evaluation of brain metastasis in JAVELIN Renal 101: efficacy of avelumab\u00a0+ axitinib (A+Ax) versus sunitinib (S)","volume":"38","author":"Jonasch","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.esmoop.2023.101598_bib29","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/bju.14461","article-title":"Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme","volume":"123","author":"De Giorgi","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.esmoop.2023.101598_bib30","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2019.37.15_suppl.4517","article-title":"Safety and efficacy of nivolumab plus ipilimumab (NIVO+IPI) in patients with advanced renal cell carcinoma (aRCC) with brain metastases: interim analysis of CheckMate 920","volume":"37","author":"Emamekhoo","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.esmoop.2023.101598_bib31","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrclinonc.2016.211","article-title":"Radiotherapy and immunotherapy: a beneficial liaison?","volume":"14","author":"Weichselbaum","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"10.1016\/j.esmoop.2023.101598_bib32","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.euo.2022.11.001","article-title":"Concurrent stereotactic ablative radiotherapy and antiangiogenic targeted agents: redefining the therapeutic strategy","volume":"6","author":"Rizzo","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.esmoop.2023.101598_bib33","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ejca.2012.02.048","article-title":"Progression free survival of first line vascular endothelial growth factor-targeted therapy is an important prognostic parameter in patients with metastatic renal cell carcinoma","volume":"48","author":"Seidel","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.esmoop.2023.101598_bib34","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1016\/S1470-2045(15)70057-4","article-title":"Response assessment criteria for brain metastases: proposal from the RANO group","volume":"16","author":"Lin","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.esmoop.2023.101598_bib35","doi-asserted-by":"crossref","first-page":"7412","DOI":"10.1158\/1078-0432.CCR-09-1624","article-title":"Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria","volume":"15","author":"Wolchok","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.esmoop.2023.101598_bib36","doi-asserted-by":"crossref","first-page":"e534","DOI":"10.1016\/S1470-2045(15)00088-1","article-title":"Immunotherapy response assessment in neuro-oncology: a report of the RANO working group","volume":"16","author":"Okada","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.esmoop.2023.101598_bib37","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1016\/S1470-2045(17)30074-8","article-title":"iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics","volume":"18","author":"Seymour","year":"2017","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2023.101598_bib38","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13046-015-0122-0","article-title":"Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?","volume":"34","author":"Santoni","year":"2015","journal-title":"J\u00a0Exp Clin Cancer Res"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702923008323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702923008323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:30:08Z","timestamp":1761856208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702923008323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S2059702923008323"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2023.101598","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An Italian multicenter retrospective real-life analysis of patients with brain metastases from renal cell carcinoma: the BMRCC study","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2023.101598","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101598"}}